ZAI LAB LTD-ADR (ZLAB) Stock News

USA - NASDAQ:ZLAB - US98887Q1040 - ADR

26.32 USD

-1.7 (-6.07%)

Last: 10/24/2025, 8:03:21 PM

26.41 USD

+0.09 (+0.34%)

After Hours: 10/24/2025, 8:03:21 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ZLAB Latest News, Press Relases and Analysis

All

Press Releases

13 hours ago - By: Zai Lab Limited

Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study

10 days ago - By: Zai Lab Limited

Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025

a month ago - By: Benzinga

Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback

2 months ago - By: Stocktwits - Mentions: AMGN

News Image

Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug

3 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

11 days ago - By: Zai Lab Limited

Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

a month ago - By: Investor's Business Daily - Mentions: PFE NYT LLY ONC ...

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

2 months ago - By: Zai Lab Limited

Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong

2 months ago - By: Zai Lab Limited

Zai Lab Announces Participation in Investor Conferences in September 2025

2 months ago - By: Zai Lab Limited

Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer

2 months ago - By: Zai Lab Limited

Zai Lab Establishes Oncology Scientific Advisory Board

3 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings

3 months ago - By: Zai Lab Limited

Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates

3 months ago - By: Yahoo Finance - Mentions: GS BAC 9688 AMGN

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment

4 months ago - By: Zai Lab Limited

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025

4 months ago - By: Zai Lab Limited

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

4 months ago - By: Yahoo Finance - Mentions: VRNA

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

4 months ago - By: Zai Lab Limited

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025

5 months ago - By: Zai Lab Limited

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting

5 months ago - By: Zai Lab Limited

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting

5 months ago - By: Zai Lab Limited

Zai Lab Announces Participation in Investor Conferences in June 2025

5 months ago - By: Zai Lab Limited

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

6 months ago - By: Zacks Investment Research

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

6 months ago - By: Zai Lab Limited

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates